Cost-Effectiveness of Insulin Glargine Versus NPH Insulin for the Treatment of Type 1 and Type 2 Diabetes Modeling the Interaction between Hypoglycemia and Glycemic Control in Switzerland

被引：0

|

作者：

Greiner, Roger-Axel

Azoulay, Marie

Brandle, Michael

机构：

来源：

DIABETES | 2009年 / 58卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：A517 / A518

页数：2

相关论文

共 50 条

[1] Cost-effectiveness of insulin glargine versus NPH insulin for the treatment of Type 2 diabetes mellitus, modeling the interaction between hypoglycemia and glycemic control in Switzerland
Braendie, M.
Azoulay, M.
Greiner, R. -A.
[J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2011, 49 (03) : 217 - 230
[2] Evaluation of the cost-effectiveness of insulin glargine versus NPH insulin for the treatment of type 1 diabetes in the UK
McEwan, Phil
Poole, Chris D.
Tetlow, Tony
Holmes, Paul
Currie, Craig J.
[J]. CURRENT MEDICAL RESEARCH AND OPINION, 2007, 23 : S7 - S19
[3] Evaluation of the cost-effectiveness of insulin glargine versus NPH insulin for the treatment of type 2 diabetes in the UK
McEwan, Phil
Poole, Chris D.
Tetlow, Tony
Holmes, Paul
Currie, Craig J.
[J]. CURRENT MEDICAL RESEARCH AND OPINION, 2007, 23 : S21 - S31
[4] The relative cost effectiveness of insulin glargine versus NPH insulin in the UK in people with type 1 diabetes
McEwan, P.
Poole, C. D.
Holmes, P.
Tetlow, A. P.
Currie, C. J.
[J]. VALUE IN HEALTH, 2006, 9 (06) : A225 - A226
[5] Exenatide versus insulin glargine: a cost-effectiveness evaluation in patients with Type 2 diabetes in Switzerland
Braendle, M.
Erny-Albrecht, K. M.
Goodall, G.
Spinas, G. A.
Streit, P.
Valentine, W. J.
[J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2009, 47 (08) : 501 - 515
[6] Cost-effectiveness of Insulin Degludec Versus Insulin Glargine in Adults with Type 1 and Type 2 Diabetes Mellitus
Evans, Marc
Chubb, Barrie
Gundgaard, Jens
[J]. DIABETES THERAPY, 2017, 8 (02) : 275 - 291
[7] Cost-effectiveness of Insulin Degludec Versus Insulin Glargine in Adults with Type 1 and Type 2 Diabetes Mellitus
Marc Evans
Barrie Chubb
Jens Gundgaard
[J]. Diabetes Therapy, 2017, 8 : 275 - 291
[8] The relationship between glycemic control and Hypoglycemia using insulin glargine-versus NPH insulin:: A meta-regression analysis in type 2 diabetes
Yki-Järvinen, H
Häring, HU
Johnson, E
Arbet-Engels, C
Nguyen, H
Zeger, S
Riddle, M
[J]. DIABETES, 2003, 52 : A149 - A150
[9] Lower severe hypoglycemia risk: Insulin glargine versus NPH insulin in type 2 diabetes
Dailey, George
Strange, Poul
[J]. AMERICAN JOURNAL OF MANAGED CARE, 2008, 14 (01): : 25 - 30
[10] Glycemic control and hypoglycemia in Asian type 2 diabetes patients treated with insulin glargine plus glimepiride versus NPH insulin plus glimepiride
Pan, CY
Bianchi-Biscay, M
Chung, KD
Kim, KW
[J]. DIABETES, 2004, 53 : A488 - A488

← 1 2 3 4 5 →